Industrial Accident Compensation Insurance Benefits on Cerebrovascular and Heart Disease in Korea.
10.3346/jkms.2003.18.4.483
- Author:
Hyeong Su KIM
1
;
Jae Wook CHOI
;
Soung Hoon CHANG
;
Kun Sei LEE
Author Information
1. Department of Internal Medicine, Konkuk University, Chungju, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Insurance Benefits;
Occupational Diseases;
Cerebrovascualr Disorders;
Heart Diseases
- MeSH:
*Accidents;
*Accidents, Occupational;
Brain Diseases/epidemiology;
Cohort Studies;
Compensation and Redress;
Costs and Cost Analysis;
Heart Diseases/epidemiology;
Human;
*Insurance Benefits;
Insurance Coverage;
Korea;
Linear Models;
Models, Statistical;
*Occupational Health;
Sensitivity and Specificity;
Time Factors;
*Workers' Compensation
- From:Journal of Korean Medical Science
2003;18(4):483-488
- CountryRepublic of Korea
- Language:English
-
Abstract:
The purpose of this study is to present the importance of work-related cerebrovascular and heart disease from the viewpoint of expenses. Using the insurance benefit paid for the 4,300 cases, this study estimated the burden of insurance benefits spent on work-related cerebrovascular and heart disease. The number of cases with work-related cerebrovascular and heart disease per 100,000 insured workers were 3.36 in 1995; they were increased to 13.16 in 2000. By the days of occurrence, the estimated number of cases were 1,336 in 2001 (95% CI: 1,211-1,460 cases) and 1,769 in 2005 (CI: 1,610-1,931 cases). The estimated average insurance benefits paid per person with work-related cerebrovascular and heart disease was 75-19 million won for medical care benefit and 56 million won for other benefits except medical care. By considering the increase in insurance payment and average pay, the predicted insurance benefits for work-related cerebrovascular and heart disease was 107.9 billion won for the 2001 cohort and 192.4 billion won for the 2005 cohort. From an economic perspective, the results will be used as important evidence for the prevention and management of work-related cerebrovascular and heart disease.
